The Scientist

» pharmaceuticals and microbiology

Most Recent

image: Giant Virus Has CRISPR-like Immune Defense

Giant Virus Has CRISPR-like Immune Defense

By | March 2, 2016

The genome of a mimivirus strain resistant to a virophage has repeated phage sequences alongside nuclease- and helicase-coding sections.

1 Comment

image: Spoiler Alert

Spoiler Alert

By | March 1, 2016

How to store microbiome samples without losing or altering diversity

1 Comment

image: Similar Data, Different Conclusions

Similar Data, Different Conclusions

By | February 23, 2016

By tweaking certain conditions of a long-running experiment on E. coli, scientists found that some bacteria could be prompted to express a mutant phenotype sooner, without the “generation of new genetic information.” The resulting debate—whether the data support evolutionary theory—is more about semantics than science.

0 Comments

image: Breast Milk Sugars Support Infant Gut Health

Breast Milk Sugars Support Infant Gut Health

By | February 18, 2016

Oligosaccharides found in breast milk stimulate the activity of gut bacteria, promoting growth in two animal models of infant malnutrition.

0 Comments

image: Abbott Acquires Diagnostics Firm

Abbott Acquires Diagnostics Firm

By | February 2, 2016

In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.

0 Comments

image: Contributors

Contributors

By | February 1, 2016

Meet some of the people featured in the February 2016 issue of The Scientist.

0 Comments

image: Speaking of Science

Speaking of Science

By | February 1, 2016

February 2016's selection of notable quotes

1 Comment

image: The Fungi Within

The Fungi Within

By | February 1, 2016

Diverse fungal species live in and on the human body.

0 Comments

image: The Mycobiome

The Mycobiome

By | February 1, 2016

The largely overlooked resident fungal community plays a critical role in human health and disease.

10 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Inflammation Drives Gut Bacteria Evolution
  4. Opinion: On “The Impact Factor Fallacy”
Business Birmingham